ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market
Holding ZVSA?
Track your performance easily

ZyVersa Therapeutics (ZVSA) Technical Analysis

120 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
ZyVersa Therapeutics’s (ZVSA) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting ZyVersa Therapeutics is a Sell.
ZyVersa Therapeutics’s (ZVSA) 20-Day exponential moving average is 4.45, while ZyVersa Therapeutics’s (ZVSA) share price is $4.41, making it a Buy.
ZyVersa Therapeutics’s (ZVSA) 50-Day exponential moving average is 4.90, while ZyVersa Therapeutics’s (ZVSA) share price is $4.41, making it a Sell.

ZyVersa Therapeutics (ZVSA) Pivot Points

Nov 10, 2024, 07:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.47
4.20
4.63
5.36
5.79
6.52
6.95
Fibonacci
4.20
4.65
4.92
5.36
5.81
6.08
6.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ZyVersa Therapeutics (ZVSA) Moving Averages

Nov 10, 2024, 07:06 AM
Period
Simple
Exponential
MA5
4.92Sell
4.87Buy
MA10
4.28Buy
4.57Buy
MA20
4.34Buy
4.45Buy
MA50
4.68Buy
4.90Sell
MA100
6.13Sell
7.47Sell
MA200
13.97Sell
17.85Sell
ZyVersa Therapeutics’s (ZVSA) 10-Day exponential moving average is 4.57, while ZyVersa Therapeutics’s (ZVSA) share price is $4.41, making it a Buy.
ZyVersa Therapeutics’s (ZVSA) 100-Day exponential moving average is 7.47, while ZyVersa Therapeutics’s (ZVSA) share price is $4.41, making it a Sell.
ZyVersa Therapeutics’s (ZVSA) stock price is $4.41 and ZyVersa Therapeutics’s (ZVSA) 50-day simple moving average is 4.68, creating a Buy signal.
ZyVersa Therapeutics’s (ZVSA) stock price is $4.41 and ZyVersa Therapeutics’s (ZVSA) 100-day simple moving average is 6.13, creating a Sell signal.
ZyVersa Therapeutics’s (ZVSA) stock price is $4.41 and ZyVersa Therapeutics’s (ZVSA) 200-day simple moving average is 13.97, creating a Sell signal.

ZyVersa Therapeutics (ZVSA) Technical Indicators

Nov 10, 2024, 07:06 AM
Name
Value
Implied Action
RSI (14)
54.21
Neutral
STOCH (9,6)
67.08
Neutral
STOCHRSI (14)
68.05
Neutral
MACD (12,26)
0.03
Sell
ADX (14)
27.58
Neutral
Williams %R
-48.44
Buy
CCI (14)
61.89
Neutral
ATR (14)
0.61
-
Ultimate Oscillator
54.75
Neutral
ROC
21.89
Buy
ZyVersa Therapeutics’s (ZVSA) Relative Strength Index (RSI) is 54.21, creating a Neutral signal.
ZyVersa Therapeutics’s (ZVSA) Trend Strength Indicator (ADX) is 27.58, creating a Neutral signal.
ZyVersa Therapeutics’s (ZVSA) Commodity Channel Index (CCI) is 61.89, creating a Neutral signal.
ZyVersa Therapeutics’s (ZVSA) Price Rate of Change (ROC) is 21.89, creating a Buy signal.

FAQ

Is ZVSA a Buy, Hold, or Sell?
Based on ZVSA’s technical indicators, ZVSA is a Hold.
    What is ZVSA’s RSI (14)?
    ZVSA’s RSI (14) is 54.21, which suggests ZVSA is a Neutral.
      What is ZVSA’s MACD?
      ZVSA’s MACD is 0.03, which suggests ZVSA is a Sell.
        What is ZVSA’s 5-day moving average?
        ZVSA’s 5-day moving average is 4.92, which suggests ZVSA is a Sell.
          What is ZVSA’s 20-day moving average?
          ZVSA 20-day moving average is 4.34, which suggests ZVSA is a Buy.
            What is ZVSA’s 50-day moving average?
            ZVSA’s 50-day moving average is 4.68, which suggests ZVSA is a Buy.
              What is ZVSA’s 200-day moving average?
              ZVSA’s 200-day moving average is 13.97, which suggests ZVSA is a Sell.
                What is ZVSA’s Williams % R (14)?
                ZVSA’s Williams % R (14) is -48.44, which suggests ZVSA is a Buy.
                  What is ZVSA’s CCI (14)?
                  ZVSA’s CCI (14) is 61.89, which suggests ZVSA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis